How Colossal is using genetic engineering to bring back the woolly mammoth

As data management platforms go, the one developed by Colossal Biosciences stands in its own large petri dish as both innovative and out of the ordinary. After all, how many software tools help develop artificial wombs using genomics and synthetic biology to return previously extinct species to the real-world food chain?

Colossal, a year-old Dallas- and Boston-based startup that emerged from stealth status last fall and says it has the goal of reconstituting a clone of the long-extinct woolly mammoth, today announced a $60 million series A financing infusion led by Thomas Tull and At One Ventures.

To Learn More Click Here